| Pharmaceuticals | Prescription drugs across cardiovascular, diabetes, CNS, anti-infectives, respiratory, oncology, and transplant therapies. | Strong brand recognition, pan-India reach, proprietary formulations, extensive R&D, and established distribution. | B2B focusing on hospitals, clinics, doctors, and pharmaceutical distributors. | Specialty chronic therapies and super-specialty segments acquired via BSV. | 10674 | 87 | Sales through prescriptions, hospital tie-ups, and specialty divisions targeting chronic and super-specialty segments. | Direct sales with competitive pricing; some specialty drugs licensed from global players. | Rising chronic disease prevalence, specialty therapy launches, increased prescription penetration, and BSV's niche products. | Manforce, Preganews, Lipirose, Statpure, Dydrogesterone, Pacliall |
| Consumer Healthcare | OTC products including condoms, pregnancy tests, supplements, and wellness products. | Market-leading brands with significant share in categories, extensive marketing and distribution. | B2C via pharmacies, retail stores, modern trade, and online platforms. | Branded consumer health products with strong market leadership positions. | 809 | 7 | Sales through retail and e-commerce channels; brand-driven consumer purchases. | Branded consumables priced competitively targeting mass markets with occasional promotions. | Growing health awareness, brand loyalty, new product launches, and e-commerce expansion. | Manforce condoms, Prega News pregnancy kits, Gas-O-Fast antacids, Daffy anti-acne, Combihale inhalers |
| Exports and International Business | Pharmaceutical exports including formulations and animal health products. | Global reach via subsidiaries, growing regulated market approvals, and diversified export portfolio. | B2B pharmaceutical distributors, healthcare providers, and emerging markets. | Specialty generics and complex formulations for regulated markets. | 1532 | 13 | International sales through subsidiaries and partnerships in US, UAE, Singapore, Nepal, and others. | Export sales via direct and subsidiary channels, regulatory compliant pricing. | Expansion to new markets, growing global footprint, focus on semi-regulated and regulated export hubs. | Select pharma brands for regulated and semi-regulated markets, US-focused generics via Lifestar Pharma |
